Condition

Gastric Cancer Peritoneal Metastases clinical trials and research

• 2Clinical trials
• 4Countries

All recruiting trials (2)

• Anti-PD-1 with chemotherapy and intraperitoneal nab-paclitaxel for untreated advanced gastric cancer with ascites

  This study tests whether adding anti-PD-1 therapy to standard chemotherapy plus intraperitoneal nab-paclitaxel can help patients with untreated advanced gastric cancer and malignant ascites.

  Recruiting Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT07855640

• Intraperitoneal paclitaxel added to standard systemic chemotherapy for gastric cancer with peritoneal metastases

  This trial tests whether giving paclitaxel directly into the abdomen together with standard systemic chemotherapy helps people with gastric cancer that has spread to the peritoneum live longer than systemic chemotherapy alone.

  Recruiting at 2 sites Phase 3 Karolinska University Hospital · Verona and 6 other locations · NCT07304271

Related topics

Quick answers

How many Gastric Cancer Peritoneal Metastases clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in Italy (1 trial), Netherlands (1 trial), Sweden (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →